KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Inventory Average (2016 - 2026)

Pacific Biosciences Of California has reported Inventory Average over the past 15 years, most recently at $51.2 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 17.72% year-over-year to $51.2 million; the TTM value through Dec 2025 reached $51.2 million, down 17.72%, while the annual FY2025 figure was $54.0 million, 6.4% down from the prior year.
  • Inventory Average for Q4 2025 was $51.2 million at Pacific Biosciences Of California, down from $53.5 million in the prior quarter.
  • Over five years, Inventory Average peaked at $68.0 million in Q2 2024 and troughed at $15.2 million in Q1 2021.
  • A 5-year average of $50.3 million and a median of $55.0 million in 2023 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: surged 107.17% in 2023 and later decreased 20.66% in 2025.
  • Year by year, Inventory Average stood at $17.1 million in 2021, then skyrocketed by 174.07% to $46.9 million in 2022, then surged by 33.08% to $62.5 million in 2023, then decreased by 0.35% to $62.2 million in 2024, then dropped by 17.72% to $51.2 million in 2025.
  • Business Quant data shows Inventory Average for PACB at $51.2 million in Q4 2025, $53.5 million in Q3 2025, and $53.9 million in Q2 2025.